breyanzi
bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastické činidlá - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.
yescarta
kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastické činidlá - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.
katéter mediastinálne argyle
the kendall, a division of tyco healthcare group lp 15 hampshire street 02048 mansfield, massachusetts spojené štáty americké -
katétre mediastinálne argyle
the kendall, a division of tyco healthcare group lp 15 hampshire street 02048 mansfield, massachusetts spojené štáty americké -
ofloxin 200
zentiva, k.s., Česká republika - ofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
itrakonazol sandoz 100 mg tvrdé kapsuly
sandoz pharmaceuticals d.d. - itrakonazol - 26 - antimycotica (lokÁlne a celkovÉ)
tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastické činidlá - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.
prokanazol 100 mg
exeltis slovakia s.r.o., slovensko - itrakonazol - 26 - antimycotica (lokÁlne a celkovÉ)
vivispray 1 mg/ml
bausch health ireland limited , Írsko - azelastín - 24 - antihistaminica, histamin
azelsan
farmak international sp. z o.o., poľsko - azelastín - 24 - antihistaminica, histamin